1 Feber A,Xi L,Luketich JD,et al.MicroRNA expression profiles of esophageal cancer[J].J Thorac Cardiovasc Surg,2008,135(2):255-260.
2 Hezova R,Kovarikova A,Srovnal J,et al.Diagnostic and prognostic potential of miR-21,miR-29c,miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus[J].Diagn Pathol,2015,10:42.
3 向正凯,严宝国.食管癌组织中microRNA-21的表达及其意义[J].肿瘤防治研究,2014,41(8):902-905.
4 Smith CM,Watson DI,Michael MZ,et al.MicroRNAs,development of Barrett′s esophagus,and progression to esophageal adenocarcinoma[J].World J Gastroenterol,2010,16(5):531-537.
5 叶敏华,叶鹏辉,张伟珠,等.唾液与血浆微小RNA-21对早期食管癌的诊断价值[J].南方医科大学学报,2014,34(6):885-889.
6 李伟,闫丛临,谭晓刚,等.唾液及血浆中微小RNA-21水平应用于早期食管癌的诊断价值[J].重庆医学,2015,44(14):1894-1896.
7 蒋敏,顾国浩,张静,等.食管癌患者外周血单个核细胞中miR-21的表达[J].中国现代医学杂志,2013,23(4):34-38.
8 郭文涛,畅灵丽,赵青,等.纳米磁分离实时荧光RT-PCR检测食管鳞状细胞癌患者血清miR-21表达的价值[J].广东医学,2016,37(6):837-840.
9 Komatsu S,Ichikawa D,Takeshita H,et al.Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma[J].Br J Cancer,2011,105(1):104-111.
10 刘凤霞,杨文清,李建勇,等.食管鳞状细胞癌组织中miR-21与ERK1/2表达及临床意义的研究[J].临床与病理杂志,2015,35(6):1130-1136.
11 李红霞,李玉芝,高峻峰,等.miRNA21抑制剂对食管癌细胞凋亡的影响[J].安徽医科大学学报,2016,51(8):1124-1127.
12 刘涛,张春,杨晨晨,等.miR-21对食管癌移植瘤模型的作用研究[J].新疆医科大学学报,2015,38(12):1462-1465.
13 Liao J,Liu R,Shi YJ,et al.Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer[J].Int J Oncol,2016,48(6):2567-2579.
14 Wu YR,Qi HJ,Deng DF,et al.MicroRNA-21 promotes cell proliferation,migration,and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer[J].Tumour Biol,2016,37(9):12061-12070.
15 Wang N,Zhang CQ,He JH,et al.MiR-21 down-regulation suppresses cell growth,invasion and induces cell apoptosis by targeting FASL,TIMP3,and RECK genes in esophageal carcinoma[J].Dig Dis Sci,2013,58(7):1863-1870.
16 刘海荣,谢斌辉,黄国红,等.miRNA-21转录调控因子的生物信息学分析[J].中山大学学报,2016,37(1):148-154.
17 Jiang LH,Ge MH,Hou XX,et al.miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma[J].Lab Invest,2015,95(12):1398-1408.
18 Venturutti L,Romero LV,Urtreger AJ,et al.Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression,PDCD4 downregulation and breast cancer metastasis[J].Oncogene,2016,35(17):2208-2222.
19 Lu X,Luo F,Liu Y,et al.The IL-6/STAT3 pathway via miR-21 is involved in the neoplastic and metastatic properties of arsenite-transformed human keratinocytes[J].Toxicol Lett,2015,237(3):191-199.
20 Liu Y,Luo F,Wang B,et al.STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells[J].Cancer Lett,2016,370(1):125-135.
21 李冰馨,史泽良,余奇,等.放射治疗前后食管癌患者外周血miR-21的动态观测及意义[J].肿瘤,2015,35(5):550-555.
22 Kurashige J,Kamohara H,Watanabe M,et al.Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma[J].J Surg Oncol,2012,106(2):188-192.
23 Komatsu S,Ichikawa D,Kawaguchi T,et al.Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma[J].Am J Cancer Res,2016,6(7):1511-1523.
24 Lv H,He Z,Wang H,et al.Differential expression of miR-21 and miR-75 in esophageal carcinoma patients and its clinical implication[J].Am J Transl Res,2016,8(7):3288-3298.
25 李晓宁.不同放疗剂量联合PF化疗食管癌患者外周血miR-21水平变化及其意义[J].中国老年学杂志,2016,36(8):1887-1888. |
